Safety and Effectiveness of the Hydrus Microstent

NATerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Open Angle GlaucomaPrimary Open Angle GlaucomaPseudoexfoliation GlaucomaPigmentary Glaucoma
Interventions
DEVICE

Hydrus Microstent

Minimally invasive glaucoma surgery device implanted into the Schlemm's canal of the eye to provide a natural outflow pathway for aqueous humor, leading to a reduction in intraocular pressure (IOP). The Hydrus Microstent is intended for lifetime use of the glaucoma patient.

PROCEDURE

Ophthalmic surgery

Implantation of the Hydrus Microstent performed under either local or topical ophthalmic anesthesia

Trial Locations (5)

33542

The Eye Clinic of Florida, Zephyrhills

45040

Cincinnati Eye / Apex Eye, Mason

48026

Fraser Eye Care Center, Fraser

53142

Eye Centers Of Racine And Kenosha, Kenosha

72712

Vold Vision PLLC, Bentonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT05198297 - Safety and Effectiveness of the Hydrus Microstent | Biotech Hunter | Biotech Hunter